Cue Health (HLTH) Stock Price, News & Analysis

Company Overview

Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Key Stats

• Today's Range: $0.04 to $0.06
• 50-Day Range: $0.04 to $0.13
• 52-Week Range: $0.04 to $0.74
• Volume: 96.00 million shs
• Average Volume: 13.38 million shs
• Market Capitalization: $6.90 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

HLTH Stock Analysis - Frequently Asked Questions

When did Cue Health IPO?

Cue Health (HLTH) raised $200 million in an initial public offering on Friday, September 24th 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

What other stocks do shareholders of Cue Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cue Health investors own include NVIDIA (NVDA), Ford Motor (F), First Solar (FSLR), Canoo (GOEV), Plug Power (PLUG), Twist Bioscience (TWST) and CRISPR Therapeutics (CRSP).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Analytical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HLTH
• CUSIP: N/A
• CIK: 1628945
• Web: www.cuehealth.com
• Phone: 858-412-8151
• Fax: N/A
• Employees: 726
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-373,460,000.00
• Net Margins: -526.48%
• Pretax Margin: -519.72%
• Return on Equity: -67.82%
• Return on Assets: -53.79%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.54
• Quick Ratio: 2.22

Sales & Book Value

• Annual Sales: $70.94 million
• Price / Sales: 0.10
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.62 per share
• Price / Book: 0.03

Miscellaneous

• Outstanding Shares: 159,090,000
• Free Float: 139,206,000
• Market Cap: $6.90 million
• Optionable: Optionable
• Beta: 1.09